Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

582
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
582
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

694
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
694
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.0K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and outcomes of urosepsis among admitted patients with urinary tract infections in Danish Emergency Departments: a retrospective cohort study.

Infectious diseases (London, England)·2026
Same author

Interferon-gamma release assay screening before solid organ transplantation in a low-incidence country: a prospective single-center cohort study.

Scientific reports·2026
Same author

Socioeconomic disparities and mortality among acute patients with sepsis: a retrospective Danish cohort study.

BMJ open·2026
Same author

Torque Teno Virus Viral Load as a Predictive Marker of Serotype-Specific Antibody Response Following the 13-Valent Conjugated Pneumococcal Vaccine in Adult Kidney Transplant Recipients: A Cohort Study.

Journal of medical virology·2026
Same author

Query into Tuberculosis Infection Screening and Management among Pregnant Migrants, Europe.

Emerging infectious diseases·2026
Same author

Computer-Aided Analysis of Photographed Chest X-Ray Films Performs Well Compared With Trained Radiologists.

Mayo Clinic proceedings. Digital health·2026

Related Experiment Video

Updated: Mar 2, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

[The current global tuberculosis state].

Christian Wejse1, Troels Lillebæk, Ole Kirk

  • 1aase.bengaard.andersen@regionh.dk.

Ugeskrift for Laeger
|May 16, 2017
PubMed
Summary

Global tuberculosis (TB) reduction trends face threats from rising drug-resistant cases. New point-of-care tests improve detection but haven't yet significantly lowered mortality rates.

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.4K

Related Experiment Videos

Last Updated: Mar 2, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.9K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.4K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Microbiology

Background:

  • Global tuberculosis (TB) incidence is rising, yet prevalence and mortality show positive reduction trends.
  • Drug-resistant TB, including multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains, poses a significant and growing global challenge.
  • Certain regions, particularly former Soviet Republic nations, face a disproportionate burden of drug-resistant TB.

Purpose of the Study:

  • To analyze the current global and regional landscape of tuberculosis, focusing on the impact of drug resistance.
  • To evaluate the role and effectiveness of emerging point-of-care (POC) diagnostic systems in high-burden countries.
  • To assess the influence of new diagnostic technologies on key tuberculosis epidemiological indicators, such as mortality.

Main Methods:

  • Review of global tuberculosis statistics and trends.
  • Analysis of the emergence and spread of multidrug-resistant and extensively drug-resistant tuberculosis.
  • Assessment of the introduction and impact of point-of-care testing systems and urine antigen detection methods.
  • Evaluation of the effect of improved detection rates on tuberculosis mortality and prevalence.

Main Results:

  • While overall global TB mortality and prevalence show declining trends, the increase in drug-resistant cases threatens these advancements.
  • Point-of-care test systems and urine antigen detection are being implemented in many TB-endemic areas, enhancing detection rates.
  • Despite improved detection capabilities, a significant breakthrough in reducing key indicators like mortality has not yet been observed.

Conclusions:

  • The rise of drug-resistant tuberculosis presents a critical challenge to global TB control efforts.
  • New diagnostic technologies offer promise for improved case detection, but their impact on mortality reduction requires further monitoring and evaluation.
  • Sustained efforts are needed to combat drug-resistant TB and translate diagnostic improvements into tangible public health outcomes.